Dr. Cataland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-8619Fax+1 614-293-6420- Is this information wrong?
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1997 - 2000
- Ohio State University HospitalResidency, Internal Medicine, 1994 - 1997
- Ohio State University College of MedicineClass of 1994
Certifications & Licensure
- OH State Medical License 1995 - 2025
- IL State Medical License 1997 - 2002
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP) Start of enrollment: 2007 Nov 01
- A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura Start of enrollment: 2021 Apr 14
Roles: Principal Investigator
- A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) Start of enrollment: 2023 Mar 21
Roles: Principal Investigator
Publications & Presentations
PubMed
- 7 citationsMyeloid growth factors.Jeffrey Crawford, James Armitage, Lodovico Balducci, Pamela Sue Becker, Douglas W Blayney
Journal of the National Comprehensive Cancer Network. 2013-10-01 - 1 citationsMyocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease.Subha V Raman, Orlando P Simonetti, Spero R Cataland, Eric H Kraut
Haematologica. 2006-10-01 - 88 citationsHow I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome.Spero R. Cataland, Haifeng M. Wu
Blood. 2014-04-17
Journal Articles
- The Role of ADAMTS13 Testing in the Diagnosis and Management of Thrombotic Microangiopathies and ThrombosisSpero R Cataland, Camila Masias, Blood
Abstracts/Posters
- African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic PurpuraSpero Cataland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Pilot Study on Biomarkers of Vascular Injury in Patients with Immune-Mediated Thrombotic Thrombocytopenic PurpuraSpero Cataland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Discordance between Free C5 and CH50 Complement Assays in Measuring Complement C5 Inhibition in Patients with aHUS Treated with RavulizumabSpero Cataland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Aware of the Rare: Diagnosing and Treating Immune-Mediated Hematologic Disorders61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Adult Clinical Non-Malignant Hematology61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Cost Is the Main Hurdle to Broad Use of Caplacizumab for TTPDecember 7th, 2020
- Ultomiris Receives Approval for Atypical Hemolytic Uremic SyndromeOctober 22nd, 2019
- Alexion Receives FDA Approval for ULTOMIRIS® (Ravulizumab-Cwvz) for Atypical Hemolytic Uremic Syndrome (aHUS)October 18th, 2019
- Join now to see all
Hospital Affiliations
- Ohio State University Wexner Medical CenterColumbus, Ohio
- The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: